Ziarco Pharma

Develops therapeutic agents for treating inflammatory and allergic diseases.

Launch date

2012

Employees

Market cap

Enterprise valuation

Dover England (HQ)

Date	Investors	Amount	Round
Oct 2012	N/A	$7.6m	Series A
Jan 2014	Sofinnova Ventures	N/A	-
Jun 2014	Innovate UK	£1.7m	Grant
Nov 2014	Lundbeckfonden Ventures New Enterprise Associates Pfizer Amgen Ventures BVF Partners Lundbeckfonden	$33.0m	Series B
Dec 2016	Novartis	N/A	Acquisition
Total Funding		AUD66.2m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Ziarco Pharma